ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Semi-Solid Formulations Drug Delivery Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-15O11563
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Semi Solid Formulations Drug Delivery Market Research Report 2022
BUY CHAPTERS

Global Semi-Solid Formulations Drug Delivery Market Research Report 2025

Code: QYRE-Auto-15O11563
Report
March 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline PLC
Bausch Health Companies
Cipla Ltd
Bayer
Viatris
3M
Merck
Novartis International
Boehringer Ingelheim
Pfizer Inc
Teva Pharmaceuticals
Bristol–Myers Squibb
Purdue Pharma
Hisamitsu Pharmaceuticals
Crescita Therpeautics
Lead Chemical

Semi-Solid Formulations Drug Delivery Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Semi-Solid Formulations Drug Delivery Market

Semi-Solid Formulations Drug Delivery Market

The global market for Semi-Solid Formulations Drug Delivery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The semi-solid drug category is comprised of creams, gels, ointments, suppositories, and other special topical dosage forms. Semi-solid drug formulations share many common attributes which include consistency, dosage uniformity, preservatives, the route of administration and their formulation basis.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Semi-Solid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semi-Solid Formulations Drug Delivery.
The Semi-Solid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Semi-Solid Formulations Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Semi-Solid Formulations Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Semi-Solid Formulations Drug Delivery Market Report

Report Metric Details
Report Name Semi-Solid Formulations Drug Delivery Market
CAGR 5%
Segment by Type
  • Creams
  • Ointments
  • Lotions
  • Gel
  • Pastes
Segment by Application
  • Home Care Settings
  • Hospitals & Clinics
  • Burn Centers
  • Other Facilities
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, GlaxoSmithKline, Bausch Health Companies, Hisamitsu Pharmaceuticals, Cipla, Bayer, Viatris, 3M, Merck & Co, Crescita Therpeautics, Novartis International, Boehringer Ingelheim, Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb, Lead Chemical, Purdue Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Semi-Solid Formulations Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Semi-Solid Formulations Drug Delivery Market report?

Ans: The main players in the Semi-Solid Formulations Drug Delivery Market are Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, GlaxoSmithKline, Bausch Health Companies, Hisamitsu Pharmaceuticals, Cipla, Bayer, Viatris, 3M, Merck & Co, Crescita Therpeautics, Novartis International, Boehringer Ingelheim, Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb, Lead Chemical, Purdue Pharma

What are the Application segmentation covered in the Semi-Solid Formulations Drug Delivery Market report?

Ans: The Applications covered in the Semi-Solid Formulations Drug Delivery Market report are Home Care Settings, Hospitals & Clinics, Burn Centers, Other Facilities

What are the Type segmentation covered in the Semi-Solid Formulations Drug Delivery Market report?

Ans: The Types covered in the Semi-Solid Formulations Drug Delivery Market report are Creams, Ointments, Lotions, Gel, Pastes

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Creams
1.2.3 Ointments
1.2.4 Lotions
1.2.5 Gel
1.2.6 Pastes
1.3 Market by Application
1.3.1 Global Semi-Solid Formulations Drug Delivery Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Home Care Settings
1.3.3 Hospitals & Clinics
1.3.4 Burn Centers
1.3.5 Other Facilities
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Semi-Solid Formulations Drug Delivery Market Perspective (2020-2031)
2.2 Global Semi-Solid Formulations Drug Delivery Growth Trends by Region
2.2.1 Global Semi-Solid Formulations Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Semi-Solid Formulations Drug Delivery Historic Market Size by Region (2020-2025)
2.2.3 Semi-Solid Formulations Drug Delivery Forecasted Market Size by Region (2026-2031)
2.3 Semi-Solid Formulations Drug Delivery Market Dynamics
2.3.1 Semi-Solid Formulations Drug Delivery Industry Trends
2.3.2 Semi-Solid Formulations Drug Delivery Market Drivers
2.3.3 Semi-Solid Formulations Drug Delivery Market Challenges
2.3.4 Semi-Solid Formulations Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Semi-Solid Formulations Drug Delivery Players by Revenue
3.1.1 Global Top Semi-Solid Formulations Drug Delivery Players by Revenue (2020-2025)
3.1.2 Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Players (2020-2025)
3.2 Global Semi-Solid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Semi-Solid Formulations Drug Delivery Revenue
3.4 Global Semi-Solid Formulations Drug Delivery Market Concentration Ratio
3.4.1 Global Semi-Solid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Semi-Solid Formulations Drug Delivery Revenue in 2024
3.5 Global Key Players of Semi-Solid Formulations Drug Delivery Head office and Area Served
3.6 Global Key Players of Semi-Solid Formulations Drug Delivery, Product and Application
3.7 Global Key Players of Semi-Solid Formulations Drug Delivery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Semi-Solid Formulations Drug Delivery Breakdown Data by Type
4.1 Global Semi-Solid Formulations Drug Delivery Historic Market Size by Type (2020-2025)
4.2 Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Type (2026-2031)
5 Semi-Solid Formulations Drug Delivery Breakdown Data by Application
5.1 Global Semi-Solid Formulations Drug Delivery Historic Market Size by Application (2020-2025)
5.2 Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
6.2 North America Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025)
6.4 North America Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
7.2 Europe Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025)
7.4 Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
8.2 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2020-2025)
8.4 Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
9.2 Latin America Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025)
9.4 Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size (2020-2031)
10.2 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025)
10.4 Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Glenmark Pharmaceuticals
11.1.1 Glenmark Pharmaceuticals Company Details
11.1.2 Glenmark Pharmaceuticals Business Overview
11.1.3 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.1.4 Glenmark Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.1.5 Glenmark Pharmaceuticals Recent Development
11.2 Galderma
11.2.1 Galderma Company Details
11.2.2 Galderma Business Overview
11.2.3 Galderma Semi-Solid Formulations Drug Delivery Introduction
11.2.4 Galderma Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.2.5 Galderma Recent Development
11.3 Johnson & Johnson Private
11.3.1 Johnson & Johnson Private Company Details
11.3.2 Johnson & Johnson Private Business Overview
11.3.3 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Introduction
11.3.4 Johnson & Johnson Private Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.3.5 Johnson & Johnson Private Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Introduction
11.4.4 GlaxoSmithKline Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Bausch Health Companies
11.5.1 Bausch Health Companies Company Details
11.5.2 Bausch Health Companies Business Overview
11.5.3 Bausch Health Companies Semi-Solid Formulations Drug Delivery Introduction
11.5.4 Bausch Health Companies Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.5.5 Bausch Health Companies Recent Development
11.6 Hisamitsu Pharmaceuticals
11.6.1 Hisamitsu Pharmaceuticals Company Details
11.6.2 Hisamitsu Pharmaceuticals Business Overview
11.6.3 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.6.4 Hisamitsu Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.6.5 Hisamitsu Pharmaceuticals Recent Development
11.7 Cipla
11.7.1 Cipla Company Details
11.7.2 Cipla Business Overview
11.7.3 Cipla Semi-Solid Formulations Drug Delivery Introduction
11.7.4 Cipla Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.7.5 Cipla Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Semi-Solid Formulations Drug Delivery Introduction
11.8.4 Bayer Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 Viatris
11.9.1 Viatris Company Details
11.9.2 Viatris Business Overview
11.9.3 Viatris Semi-Solid Formulations Drug Delivery Introduction
11.9.4 Viatris Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.9.5 Viatris Recent Development
11.10 3M
11.10.1 3M Company Details
11.10.2 3M Business Overview
11.10.3 3M Semi-Solid Formulations Drug Delivery Introduction
11.10.4 3M Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.10.5 3M Recent Development
11.11 Merck & Co
11.11.1 Merck & Co Company Details
11.11.2 Merck & Co Business Overview
11.11.3 Merck & Co Semi-Solid Formulations Drug Delivery Introduction
11.11.4 Merck & Co Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.11.5 Merck & Co Recent Development
11.12 Crescita Therpeautics
11.12.1 Crescita Therpeautics Company Details
11.12.2 Crescita Therpeautics Business Overview
11.12.3 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Introduction
11.12.4 Crescita Therpeautics Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.12.5 Crescita Therpeautics Recent Development
11.13 Novartis International
11.13.1 Novartis International Company Details
11.13.2 Novartis International Business Overview
11.13.3 Novartis International Semi-Solid Formulations Drug Delivery Introduction
11.13.4 Novartis International Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.13.5 Novartis International Recent Development
11.14 Boehringer Ingelheim
11.14.1 Boehringer Ingelheim Company Details
11.14.2 Boehringer Ingelheim Business Overview
11.14.3 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Introduction
11.14.4 Boehringer Ingelheim Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.14.5 Boehringer Ingelheim Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Semi-Solid Formulations Drug Delivery Introduction
11.15.4 Pfizer Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 Teva Pharmaceuticals
11.16.1 Teva Pharmaceuticals Company Details
11.16.2 Teva Pharmaceuticals Business Overview
11.16.3 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Introduction
11.16.4 Teva Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.16.5 Teva Pharmaceuticals Recent Development
11.17 Bristol Myers Squibb
11.17.1 Bristol Myers Squibb Company Details
11.17.2 Bristol Myers Squibb Business Overview
11.17.3 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Introduction
11.17.4 Bristol Myers Squibb Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.17.5 Bristol Myers Squibb Recent Development
11.18 Lead Chemical
11.18.1 Lead Chemical Company Details
11.18.2 Lead Chemical Business Overview
11.18.3 Lead Chemical Semi-Solid Formulations Drug Delivery Introduction
11.18.4 Lead Chemical Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.18.5 Lead Chemical Recent Development
11.19 Purdue Pharma
11.19.1 Purdue Pharma Company Details
11.19.2 Purdue Pharma Business Overview
11.19.3 Purdue Pharma Semi-Solid Formulations Drug Delivery Introduction
11.19.4 Purdue Pharma Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025)
11.19.5 Purdue Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline PLC
Bausch Health Companies
Cipla Ltd
Bayer
Viatris
3M
Merck
Novartis International
Boehringer Ingelheim
Pfizer Inc
Teva Pharmaceuticals
Bristol–Myers Squibb
Purdue Pharma
Hisamitsu Pharmaceuticals
Crescita Therpeautics
Lead Chemical
List of Tables
 Table 1. Global Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Creams
 Table 3. Key Players of Ointments
 Table 4. Key Players of Lotions
 Table 5. Key Players of Gel
 Table 6. Key Players of Pastes
 Table 7. Global Semi-Solid Formulations Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Semi-Solid Formulations Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Semi-Solid Formulations Drug Delivery Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Semi-Solid Formulations Drug Delivery Market Share by Region (2020-2025)
 Table 11. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Semi-Solid Formulations Drug Delivery Market Share by Region (2026-2031)
 Table 13. Semi-Solid Formulations Drug Delivery Market Trends
 Table 14. Semi-Solid Formulations Drug Delivery Market Drivers
 Table 15. Semi-Solid Formulations Drug Delivery Market Challenges
 Table 16. Semi-Solid Formulations Drug Delivery Market Restraints
 Table 17. Global Semi-Solid Formulations Drug Delivery Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Semi-Solid Formulations Drug Delivery Market Share by Players (2020-2025)
 Table 19. Global Top Semi-Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Formulations Drug Delivery as of 2024)
 Table 20. Ranking of Global Top Semi-Solid Formulations Drug Delivery Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Semi-Solid Formulations Drug Delivery Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Semi-Solid Formulations Drug Delivery, Headquarters and Area Served
 Table 23. Global Key Players of Semi-Solid Formulations Drug Delivery, Product and Application
 Table 24. Global Key Players of Semi-Solid Formulations Drug Delivery, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Semi-Solid Formulations Drug Delivery Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Type (2020-2025)
 Table 28. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Type (2026-2031)
 Table 30. Global Semi-Solid Formulations Drug Delivery Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Application (2020-2025)
 Table 32. Global Semi-Solid Formulations Drug Delivery Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Semi-Solid Formulations Drug Delivery Revenue Market Share by Application (2026-2031)
 Table 34. North America Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Glenmark Pharmaceuticals Company Details
 Table 50. Glenmark Pharmaceuticals Business Overview
 Table 51. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Product
 Table 52. Glenmark Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 53. Glenmark Pharmaceuticals Recent Development
 Table 54. Galderma Company Details
 Table 55. Galderma Business Overview
 Table 56. Galderma Semi-Solid Formulations Drug Delivery Product
 Table 57. Galderma Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 58. Galderma Recent Development
 Table 59. Johnson & Johnson Private Company Details
 Table 60. Johnson & Johnson Private Business Overview
 Table 61. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Product
 Table 62. Johnson & Johnson Private Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 63. Johnson & Johnson Private Recent Development
 Table 64. GlaxoSmithKline Company Details
 Table 65. GlaxoSmithKline Business Overview
 Table 66. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Product
 Table 67. GlaxoSmithKline Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 68. GlaxoSmithKline Recent Development
 Table 69. Bausch Health Companies Company Details
 Table 70. Bausch Health Companies Business Overview
 Table 71. Bausch Health Companies Semi-Solid Formulations Drug Delivery Product
 Table 72. Bausch Health Companies Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 73. Bausch Health Companies Recent Development
 Table 74. Hisamitsu Pharmaceuticals Company Details
 Table 75. Hisamitsu Pharmaceuticals Business Overview
 Table 76. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Product
 Table 77. Hisamitsu Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 78. Hisamitsu Pharmaceuticals Recent Development
 Table 79. Cipla Company Details
 Table 80. Cipla Business Overview
 Table 81. Cipla Semi-Solid Formulations Drug Delivery Product
 Table 82. Cipla Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 83. Cipla Recent Development
 Table 84. Bayer Company Details
 Table 85. Bayer Business Overview
 Table 86. Bayer Semi-Solid Formulations Drug Delivery Product
 Table 87. Bayer Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 88. Bayer Recent Development
 Table 89. Viatris Company Details
 Table 90. Viatris Business Overview
 Table 91. Viatris Semi-Solid Formulations Drug Delivery Product
 Table 92. Viatris Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 93. Viatris Recent Development
 Table 94. 3M Company Details
 Table 95. 3M Business Overview
 Table 96. 3M Semi-Solid Formulations Drug Delivery Product
 Table 97. 3M Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 98. 3M Recent Development
 Table 99. Merck & Co Company Details
 Table 100. Merck & Co Business Overview
 Table 101. Merck & Co Semi-Solid Formulations Drug Delivery Product
 Table 102. Merck & Co Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 103. Merck & Co Recent Development
 Table 104. Crescita Therpeautics Company Details
 Table 105. Crescita Therpeautics Business Overview
 Table 106. Crescita Therpeautics Semi-Solid Formulations Drug Delivery Product
 Table 107. Crescita Therpeautics Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 108. Crescita Therpeautics Recent Development
 Table 109. Novartis International Company Details
 Table 110. Novartis International Business Overview
 Table 111. Novartis International Semi-Solid Formulations Drug Delivery Product
 Table 112. Novartis International Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 113. Novartis International Recent Development
 Table 114. Boehringer Ingelheim Company Details
 Table 115. Boehringer Ingelheim Business Overview
 Table 116. Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Product
 Table 117. Boehringer Ingelheim Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 118. Boehringer Ingelheim Recent Development
 Table 119. Pfizer Company Details
 Table 120. Pfizer Business Overview
 Table 121. Pfizer Semi-Solid Formulations Drug Delivery Product
 Table 122. Pfizer Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 123. Pfizer Recent Development
 Table 124. Teva Pharmaceuticals Company Details
 Table 125. Teva Pharmaceuticals Business Overview
 Table 126. Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Product
 Table 127. Teva Pharmaceuticals Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 128. Teva Pharmaceuticals Recent Development
 Table 129. Bristol Myers Squibb Company Details
 Table 130. Bristol Myers Squibb Business Overview
 Table 131. Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Product
 Table 132. Bristol Myers Squibb Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 133. Bristol Myers Squibb Recent Development
 Table 134. Lead Chemical Company Details
 Table 135. Lead Chemical Business Overview
 Table 136. Lead Chemical Semi-Solid Formulations Drug Delivery Product
 Table 137. Lead Chemical Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 138. Lead Chemical Recent Development
 Table 139. Purdue Pharma Company Details
 Table 140. Purdue Pharma Business Overview
 Table 141. Purdue Pharma Semi-Solid Formulations Drug Delivery Product
 Table 142. Purdue Pharma Revenue in Semi-Solid Formulations Drug Delivery Business (2020-2025) & (US$ Million)
 Table 143. Purdue Pharma Recent Development
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources
 Table 147. Authors List of This Report


List of Figures
 Figure 1. Semi-Solid Formulations Drug Delivery Picture
 Figure 2. Global Semi-Solid Formulations Drug Delivery Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Semi-Solid Formulations Drug Delivery Market Share by Type: 2024 VS 2031
 Figure 4. Creams Features
 Figure 5. Ointments Features
 Figure 6. Lotions Features
 Figure 7. Gel Features
 Figure 8. Pastes Features
 Figure 9. Global Semi-Solid Formulations Drug Delivery Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Semi-Solid Formulations Drug Delivery Market Share by Application: 2024 VS 2031
 Figure 11. Home Care Settings Case Studies
 Figure 12. Hospitals & Clinics Case Studies
 Figure 13. Burn Centers Case Studies
 Figure 14. Other Facilities Case Studies
 Figure 15. Semi-Solid Formulations Drug Delivery Report Years Considered
 Figure 16. Global Semi-Solid Formulations Drug Delivery Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Semi-Solid Formulations Drug Delivery Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Semi-Solid Formulations Drug Delivery Market Share by Region: 2024 VS 2031
 Figure 19. Global Semi-Solid Formulations Drug Delivery Market Share by Players in 2024
 Figure 20. Global Top Semi-Solid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Semi-Solid Formulations Drug Delivery as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Semi-Solid Formulations Drug Delivery Revenue in 2024
 Figure 22. North America Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Semi-Solid Formulations Drug Delivery Market Share by Country (2020-2031)
 Figure 24. United States Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Semi-Solid Formulations Drug Delivery Market Share by Country (2020-2031)
 Figure 28. Germany Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Semi-Solid Formulations Drug Delivery Market Share by Region (2020-2031)
 Figure 36. China Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Semi-Solid Formulations Drug Delivery Market Share by Country (2020-2031)
 Figure 44. Mexico Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Semi-Solid Formulations Drug Delivery Market Share by Country (2020-2031)
 Figure 48. Turkey Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Semi-Solid Formulations Drug Delivery Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Glenmark Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 52. Galderma Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 53. Johnson & Johnson Private Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 54. GlaxoSmithKline Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 55. Bausch Health Companies Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 56. Hisamitsu Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 57. Cipla Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 58. Bayer Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 59. Viatris Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 60. 3M Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 61. Merck & Co Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 62. Crescita Therpeautics Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 63. Novartis International Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 64. Boehringer Ingelheim Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 65. Pfizer Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 67. Bristol Myers Squibb Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 68. Lead Chemical Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 69. Purdue Pharma Revenue Growth Rate in Semi-Solid Formulations Drug Delivery Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26N13078
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3L13782
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26S13718
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16S12875
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions